...
首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladderurinary diversion
【24h】

Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladderurinary diversion

机译:根治性膀胱切除伴原位新膀胱泌尿系统转移后的术后感染和预防性抗生素管理

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to investigate the association between prophylactic antibiotic administration (PAA) andpost-operative infection in radical cystectomy with orthotopic neobladder urinary diversion carried out for patients withbladder cancer. Fifty-seven consecutive cases were analyzed retrospectively. Post-operative infections were categorized asurinary tract, wound, and remote infections. We used the antibiotics tazobactam/piperacillin (TAZ/PIPC), sulbactam/ampicillin(SBT/ABPC), flomoxef (FMOX), cefazolin (CEZ), cefotiam (CTM), and cefmetazole (CMZ). Twenty-five (43.9%) patients hadpost-operative infections. Five of these (8.77%) patients had wound infections, 22 (38.6%) patients had urinary tractinfections, and 2 (3.51%) had remote infections. Our statistical analysis demonstrated that the patients with TAZ/PIPC usedfor PAA (5/18: 27.8%) had a significantly lower post-operative infection rate than patients with other antibiotics (24/39:61.5%) (p = 0.0442). In addition, the patients with a shorter-duration PAA (within 72 h after the operation (48-72 h)) had asignificantly lower rate of post-operative infections (12/33: 36.4%) than those with longer-duration PAA (longer than 72-96 hafter the operation) (16/24: 66.7%) (p = 0.0239). Taken together, these results suggest that TAZ/PIPC with shorter PAAduration (within 72 h) might lead to a lower rate of post-operative infections. In conclusion, our data showed that PAA withTAZ/PIPC with a shorter duration PAA (within 72 h) might be recommended for radical cystectomy with orthotopic neobladderreconstruction. A prospective study based on our data is desirable to establish or revise guidelines for prophylacticmedication for preventing post-operative infection after radical cystectomy with orthotopic neobladder urinary diversion.
机译:这项研究的目的是探讨对膀胱癌患者进行的原发性新膀胱尿流改道的根治性膀胱切除术中预防性抗生素管理(PAA)与术后感染之间的关系。回顾性分析了57例连续病例。术后感染分为泌尿道感染,伤口感染和远端感染。我们使用了抗生素他唑巴坦/哌拉西林(TAZ / PIPC),舒巴坦/氨苄西林(SBT / ABPC),氟莫昔芬(FMOX),头孢唑林(CEZ),头孢替安(CTM)和头孢甲唑(CMZ)。 25名(43.9%)的患者术后感染。这些患者中有5名(8.77%)患有伤口感染,22名(38.6%)患有尿路感染,其中2名(3.51%)患有远处感染。我们的统计分析表明,用于PAA的TAZ / PIPC患者(5/18:27.8%)的术后感染率明显低于其他抗生素患者(24/39:61.5%)(p = 0.0442)。此外,PAA时间较短的患者(术后72小时内(48-72小时))的术后感染率(12/33:36.4%)明显低于PAA时间较长的患者(12/33:36.4%)。手术后超过72-96小时)(16/24:66.7%)(p = 0.0239)。综上所述,这些结果表明,PAA持续时间较短(72小时内)的TAZ / PIPC可能导致术后感染率降低。总之,我们的数据表明,PAA与TAZ / PIPC持续时间较短(72小时内)的PAA可能建议用于原位新膀胱重建的根治性膀胱切除术。根据我们的数据进行前瞻性研究对于建立或修订预防性用药指南是必要的,以预防原位新膀胱尿路改道行根治性膀胱切除术后预防感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号